Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance

Go back to Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 225.92 +1.26 (0.56%)
Previous Close $224.66    52 Week High $160.00 
Open $226.16    52 Week Low $95.80 
Day High $227.86    P/E 41.99 
Day Low $224.27    EPS $5.38 
Volume 979,966